Implementation of an Evidence-Based Educational Resource for Children With Mild Traumatic Brain Injury (POCKIT)

February 10, 2026 updated by: Baylor Research Institute
The goal of this prospective, observational study is to (1) collaborate with our stakeholders to identify essential mTBI-information from existing evidence-based materials to develop a Post-mTBI Educational Resource for children with mTBI and their parents and (2) implement our Post-mTBI Educational Resource into clinical practice to determine feasibility, acceptability, and appropriateness at Baylor Scott and White (BSW) clinical sites that treat children with mTBI.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

14

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Frisco, Texas, United States, 75034
        • BSW Primary Care at The Star
      • Frisco, Texas, United States, 75034
        • BSW Sports Concussion Program
      • Temple, Texas, United States, 76502
        • McLane Children's Hospital at BSW Temple Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Potential stakeholders will be between the ages of 8 and 99 years.

Description

Inclusion Criteria:

  • children and young adults who are student athletes
  • they have experienced a mTBI
  • parents, coaches, and professional stakeholders (e.g., athletic trainers, school nurses, school administrators, physicians, healthcare administrators, local and national entities, community partners).
  • Stakeholders were part of our previous Engagement Award.

Exclusion Criteria:

  • Individuals younger than 8 years old
  • Anyone who does not meet the above criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Advisory Board (AB)
Our target AB of stakeholders include children and young adults who are student athletes and have experienced mTBI, parents, coaches, and professional stakeholders (e.g., athletic trainers, school nurses, school administrators, physicians, healthcare administrators, local and national entities, community partners)
Other: Post-mTBI Educational Resource
Activate clinicians and clinic administrators at BSW clinical sites that treat children with mTBI to implement the Post-mTBI Educational Resource.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Engagement
Time Frame: through study completion, an average of 3 years
# of Advisory Board members
through study completion, an average of 3 years
Engagement
Time Frame: through study completion, an average of 3 years
# of Engagment Partners
through study completion, an average of 3 years
Engagement
Time Frame: through study completion, an average of 3 years
Feedback and Satisfaction on The Patient Engagement in Research Scale (PEIRS). Total scores are calculated on a scale of 0 to 100, where higher scores indicate more meaningful engagement.
through study completion, an average of 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Baylor Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 4, 2025

Primary Completion (Actual)

December 8, 2025

Study Completion (Actual)

December 8, 2025

Study Registration Dates

First Submitted

March 3, 2025

First Submitted That Met QC Criteria

February 10, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 90IFDV0035

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Concussion, Mild Traumatic Brain Injury

Clinical Trials on Post-mTBI Educational Resource

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe